Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study.

Gouveia, Andre G; Moraes, Fabio Y; Lima, Renato P; Viani, Gustavo A

Gouveia, Andre G; Moraes, Fabio Y; Lima, Renato P; Viani, Gustavo A.

Afiliação

Gouveia AG; Radiation Oncology Department, Americas Centro de Oncologia Integrado, Rio de Janeiro, RJ, Brazil.
Moraes FY; Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
Lima RP; Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
Viani GA; Department of Oncology, Division of Radiation Oncology, Kingston General Hospital, Queen's University, Kingston, ON, Canada.

Rep Pract Oncol Radiother ; 27(4): 659-665, 2022.

Article em En | MEDLINE | ID: mdl-36196422

Palavras-chave

COVID-19; prostate cancer; radical prostatectomy; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google